[{"abstract": "The American health care giant will pay $1 billion to the Irish drug maker Elan to gain access to Alzheimer\u2019s disease treatments.", "web_url": "https://www.nytimes.com/2009/07/03/business/03drug.html", "snippet": "The American health care giant will pay $1 billion to the Irish drug maker Elan to gain access to Alzheimer\u2019s disease treatments.", "lead_paragraph": "Johnson & Johnson, the health care giant, will pay $1 billion to the Irish biotechnology company Elan to gain access to Alzheimer\u2019s disease treatments, the companies said Thursday.", "print_section": "B", "print_page": "4", "source": "The New York Times", "multimedia": [], "headline": {"main": "Johnson & Johnson Buys Access to an Alzheimer\u2019s Drug", "kicker": null, "content_kicker": null, "print_headline": "Johnson & Johnson Buys Access to an Alzheimer\u2019s Drug", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Johnson & Johnson Inc", "rank": 2, "major": "N"}, {"name": "subject", "value": "Alzheimer's Disease", "rank": 3, "major": "N"}], "pub_date": "2009-07-02T13:10:04+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By David Jolly", "person": [{"firstname": "David", "middlename": null, "lastname": "Jolly", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/5b50a5df-17e6-5ea9-bbfb-f8978bb011cc", "word_count": 480, "uri": "nyt://article/5b50a5df-17e6-5ea9-bbfb-f8978bb011cc"}, {"abstract": "Elan\u2019s shares soared Thursday after Johnson & Johnson said it would pay $1 billion to the Irish drug maker to gain access to Alzheimer\u2019s disease treatments.", "web_url": "https://dealbook.nytimes.com/2009/07/02/jj-takes-1-billion-elan-stake/", "snippet": "Elan\u2019s shares soared Thursday after Johnson & Johnson said it would pay $1 billion to the Irish drug maker to gain access to Alzheimer\u2019s disease treatments.", "lead_paragraph": "Elan\u2018s shares soared Thursday after Johnson & Johnson, the American health care giant, said it would pay $1 billion to the Irish drug maker to gain access to Alzheimer\u2019s disease treatments.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Johnson & Johnson to Take Stake in Elan", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2009-07-02T14:07:15+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/306e27ae-1016-528f-a819-5dcbb129aad9", "word_count": 193, "uri": "nyt://article/306e27ae-1016-528f-a819-5dcbb129aad9"}]